Praetorian Pr LLC Anebulo Pharmaceuticals, Inc. Transaction History
Praetorian Pr LLC
- $250 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding ANEB
# of Institutions
16Shares Held
22.6MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA15.5MShares$31.6 Million21.77% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.04MShares$6.19 Million0.26% of portfolio
-
Mangrove Partners New York, NY2.53MShares$5.15 Million0.66% of portfolio
-
Lvw Advisors, LLC633KShares$1.29 Million0.13% of portfolio
-
Morgan Stanley New York, NY420KShares$856,7870.0% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $52.3M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...